Green R, Miller J, Crosby W
Blood. 1981 May;57(5):866-72.
We have exploited the physiologic mechanism for removal of red cells from the circulation to target the iron chelator desferrioxamine to reticuloendothelial iron stores. Compared with free desferrioxamine injected intravenously, the same dose of desferrioxamine entrapped in resealed red blood cell ghosts resulted in a fourfold to fivefold increase in excretion of radioiron in rats with a selective 59Fe radiolabel of reticuloendothelial iron stores. Desferrioxamine in red cell ghosts did not enhance excretion in rats with selective radiolabeling of parenchymal iron stores. In rats with uniformly radiolabeled iron stores, desferrioxamine in red cell ghosts produced an eightfold to ninefold greater loss of iron in the urine free desferrioxamine intravenously or by slow subcutaneous infusion. Desferrioxamine in red cell ghosts resulted in significantly greater fecal excretion of iron than intravenous desferrioxamine, but desferrioxamine in red cell ghosts and subcutaneous desferrioxamine infusion resulted in similar fecal iron excretion. Clinical application of the red cell ghost method for administration of desferrioxamine and other iron chelators may ber useful for improvement of iron chelation efficiency.
我们利用了循环中红细胞清除的生理机制,将铁螯合剂去铁胺靶向于网状内皮系统的铁储存部位。与静脉注射游离去铁胺相比,相同剂量包裹于重封红细胞影中的去铁胺,在选择性用59Fe对网状内皮系统铁储存进行放射性标记的大鼠中,导致放射性铁的排泄增加了4至5倍。红细胞影中的去铁胺在实质细胞铁储存选择性放射性标记的大鼠中并未增强排泄。在铁储存均匀放射性标记的大鼠中,红细胞影中的去铁胺比静脉注射或缓慢皮下输注游离去铁胺导致尿中铁的损失大8至9倍。红细胞影中的去铁胺导致的粪便铁排泄明显多于静脉注射去铁胺,但红细胞影中的去铁胺和皮下注射去铁胺导致的粪便铁排泄相似。红细胞影法用于去铁胺和其他铁螯合剂给药的临床应用可能有助于提高铁螯合效率。